MacroGenics Inc.(MGNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MGNX MacroGenics Inc.

交易中 06-11 15:29:25 EDT

4.03

+0.16

+4.01%

最高4.08	最低3.81	成交量55.28万
今开3.84	昨收3.87	日振幅6.98%
总市值2.55亿	流通市值2.12亿	总股本6,326万
成交额219.86万	换手率1.05%	流通股本5,266万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MGNX","market":"US","secType":"STK","nameCN":"MacroGenics Inc.","latestPrice":4.025,"timestamp":1781206160263,"preClose":3.87,"halted":0,"volume":552802,"delay":0,"changeRate":0.040051679586563374,"floatShares":52660280,"shares":63258532,"eps":-1.114058,"marketStatus":"交易中","change":0.155,"latestTime":"06-11 15:29:25 EDT","open":3.84,"high":4.08,"low":3.81,"amount":2198620.145658,"amplitude":0.069767,"askPrice":4.03,"askSize":148,"bidPrice":4.02,"bidSize":1046,"shortable":3,"etf":0,"ttmEps":-1.114058,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1781208000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1381377600000,"exchange":"NASDAQ","adjPreClose":3.87,"postHourTrading":{"tag":"盘后","latestPrice":3.85,"preClose":3.87,"latestTime":"19:47 EDT","volume":2527,"amount":9758.9255,"timestamp":1781135275504,"change":-0.02,"changeRate":-0.005168,"amplitude":0.005168},"volumeRatio":1.086761,"impliedVol":0.8106,"impliedVolPercentile":0.3944},"requestUrl":"/m/hq/s/MGNX","defaultTab":"news","newsList":[{"id":"1102777062","title":"MacroGenics Inc. 将与Bora达成供应安排，以满足其内部管线需求","url":"https://stock-news.laohu8.com/highlight/detail?id=1102777062","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102777062?lang=zh_cn&edition=full","pubTime":"2026-05-12 05:22","pubTimestamp":1778534534,"startTime":"0","endTime":"0","summary":"MacroGenics Inc. 宣布，将与其合作伙伴Bora就工艺开发和原料药生产达成一项供应安排。此项合作旨在满足MacroGenics自身研发管线的内部需求，为其后续的临床开发与商业化进程提供关键的物质保障。\n通过此项安排，MacroGenics将借助Bora在生物制药工艺开发与生产领域的专业能力，确保其管线候选药物能够获得稳定、高质量的原料药供应。此举标志着公司正积极为其在研产品的后续推进奠定坚实的供应链基础，是管线战略实施的重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MGNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106365320","title":"MacroGenics Inc. 与Sagard达成里程碑协议：2032年9月30日前实现1.7倍或2.0倍投资回报后，所有特许权将回归MacroGenics","url":"https://stock-news.laohu8.com/highlight/detail?id=1106365320","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106365320?lang=zh_cn&edition=full","pubTime":"2026-05-04 19:32","pubTimestamp":1777894339,"startTime":"0","endTime":"0","summary":"MacroGenics Inc. (MGNX) 宣布一项重大资产回收安排。根据协议条款，投资机构Sagard在2032年9月30日前实现1.7倍或2.0倍的投资回报后，所有相关特许权将自动回归MacroGenics公司。\n这一里程碑式的协议为MacroGenics未来的资产权益提供了明确路径。当Sagard达到预设的投资回报阈值时，特许权利益将完成闭环流转，最终回归生物制药公司MacroGenics的掌控之中。\n该安排既保障了投资方的收益目标，又确保了MacroGenics长期权益的完整性。通过设定明确的时间节点和回报标准，双方构建了双赢的合作框架，为生物技术领域的投融资模式提供了创新范本。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MGNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126354007","title":"MacroGenics Inc. 将依据修订后方案招募新受试者，并引入额外风险缓解措施","url":"https://stock-news.laohu8.com/highlight/detail?id=1126354007","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126354007?lang=zh_cn&edition=full","pubTime":"2026-04-09 04:32","pubTimestamp":1775680323,"startTime":"0","endTime":"0","summary":"MacroGenics Inc. 宣布，其临床试验方案已获修订，新方案纳入了额外的风险缓解措施。依据更新后的研究方案，公司计划开始招募新的参与者加入该项研究。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614035745","title":"患者死亡引 FDA 出手 PD-1/CTLA-4 双抗临床试验遇阻","url":"https://stock-news.laohu8.com/highlight/detail?id=2614035745","media":"生物制品圈","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614035745?lang=zh_cn&edition=full","pubTime":"2026-02-25 11:54","pubTimestamp":1771991682,"startTime":"0","endTime":"0","summary":"摘要：2026 年 2 月 24 日，FDA 下令叫停 MacroGenics 旗下核心药物 lorigerlimab 的二期临床试验入组工作，起因是试验中一名患者因严重副作用离世，另有四名患者出现严重不良反应。这家总部位于马里兰州的生物科技公司此前已自主暂停入组，此次 FDA 的指令让这款PD-1/CTLA-4 双抗药物的研发再添阴霾，而这并非该公司首次遭遇临床安全危机。隔天，FDA 的正式叫停指令落地，让这场自主暂停变成了官方强制的临床限制。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225115824a4c58347&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225115824a4c58347&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MGNX","LU1169589451.USD","PD","BK4023","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129202353","title":"MacroGenics主动通知FDA暂停Linnet试验新患者入组后，FDA启动部分临床暂停","url":"https://stock-news.laohu8.com/highlight/detail?id=1129202353","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129202353?lang=zh_cn&edition=full","pubTime":"2026-02-24 07:16","pubTimestamp":1771888570,"startTime":"0","endTime":"0","summary":"MacroGenics Inc. (MGNX) 在主动向美国食品药品监督管理局（FDA）通报其已暂停Linnet试验新参与者招募工作后，FDA已对该公司启动部分临床暂停。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MGNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148842370","title":"美国FDA对MacroGenics公司Lorigerlimab二期Linnet研究实施部分临床暂停","url":"https://stock-news.laohu8.com/highlight/detail?id=1148842370","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148842370?lang=zh_cn&edition=full","pubTime":"2026-02-24 07:15","pubTimestamp":1771888511,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已对MacroGenics Inc. (MGNX) 旗下药物Lorigerlimab的二期Linnet研究实施了部分临床暂停。这一决定意味着，在相关问题得到解决并获得FDA认可之前，该研究将暂停招募新的受试者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516865066","title":"Macrogenics, Inc.盘中异动 股价大跌5.08%报2.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516865066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516865066?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:40","pubTimestamp":1741030827,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时40分，Macrogenics, Inc.股票出现异动，股价急速下跌5.08%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Biocardia, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4555.49%、207.50%、181.60%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304034027abe68911&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304034027abe68911&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512651541","title":"Macrogenics, Inc.盘中异动 大幅上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512651541","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512651541?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:43","pubTimestamp":1739889818,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时43分，Macrogenics, Inc.股票出现波动，股价快速拉升5.08%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、莱斯康制药涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为303.75%、109.00%、87.44%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Jasper Therapeutics Inc C/Wts 24/09/2026 、Conduit Pharmaceuticals Inc.，振幅分别为41.79%、34.04%、26.83%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822433896279a11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822433896279a11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MGNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511405614","title":"Macrogenics, Inc.盘中异动 急速拉升5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511405614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511405614?lang=zh_cn&edition=full","pubTime":"2025-02-15 04:24","pubTimestamp":1739564676,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日04时24分，Macrogenics, Inc.股票出现波动，股价快速上涨5.28%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Moolec Science Sa C/Wts 、Moleculin Biotech, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3175.05%、810.95%、633.03%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Moleculin Biotech, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为74.35%、71.65%、66.45%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502150424369885d6bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502150424369885d6bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MGNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510338469","title":"Macrogenics, Inc.盘中异动 早盘大幅下挫5.12%报2.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510338469","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510338469?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:06","pubTimestamp":1739286418,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时06分，Macrogenics, Inc.股票出现异动，股价快速下跌5.12%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为1.38%。其相关个股中，Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2504.12%、735.72%、328.86%，振幅较大的相关个股有Dominari Holdings Inc.、In8Bio, Inc.、Ocean Biomedical, Inc.，振幅分别为52.11%、37.99%、37.16%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112306589881c403&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112306589881c403&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCEA","BK4139","MGNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509998725","title":"Macrogenics, Inc.盘中异动 股价大跌5.05%报2.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509998725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509998725?lang=zh_cn&edition=full","pubTime":"2025-02-08 00:06","pubTimestamp":1738944392,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日00时06分，Macrogenics, Inc.股票出现异动，股价大幅跳水5.05%。截至发稿，该股报2.63美元/股，成交量25.1804万股，换手率0.40%，振幅4.99%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。它的产品包括MARGENZA，用于治疗患有转移性HER2阳性乳腺癌的成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208000633961b49ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208000633961b49ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509208040","title":"Macrogenics, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509208040","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509208040?lang=zh_cn&edition=full","pubTime":"2025-02-06 23:47","pubTimestamp":1738856829,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日23时47分，Macrogenics, Inc.股票出现异动，股价急速下跌5.03%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Azitra Inc涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Azitra Inc较为活跃，换手率分别为5559.28%、1371.99%、136.38%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Azitra Inc、Transcode Therapeutics, Inc.，振幅分别为103.10%、42.43%、39.93%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206234709987c9b2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206234709987c9b2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509253289","title":"Macrogenics, Inc.盘中异动 股价大涨5.09%报3.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509253289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509253289?lang=zh_cn&edition=full","pubTime":"2025-02-06 03:48","pubTimestamp":1738784896,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日03时48分，Macrogenics, Inc.股票出现波动，股价急速上涨5.09%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为2.49%。其相关个股中，Immatics N V C/Wts 01/07/2025 、Transcode Therapeutics, Inc.、Invivyd, Inc.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4646.92%、2362.21%、1762.88%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为132.24%、99.51%、75.00%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206034816a23abc88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206034816a23abc88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MGNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508140890","title":"Macrogenics, Inc.盘中异动 早盘快速下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508140890","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508140890?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:15","pubTimestamp":1738595743,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时15分，Macrogenics, Inc.股票出现波动，股价大幅跳水5.00%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为0.78%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为518.08%、403.11%、282.15%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为136.56%、75.23%、50.76%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020323154496170370&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020323154496170370&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MGNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506898645","title":"Macrogenics, Inc.盘中异动 急速上涨5.06%报3.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506898645","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506898645?lang=zh_cn&edition=full","pubTime":"2025-01-25 00:43","pubTimestamp":1737736989,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日00时43分，Macrogenics, Inc.股票出现异动，股价大幅上涨5.06%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Neuphoria Therapeutics Inc.、Evaxion Biotech As、Pmgc Holdings Inc.涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为3928.61%、2142.50%、1599.29%，振幅较大的相关个股有Neuphoria Therapeutics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Evaxion Biotech As，振幅分别为179.66%、134.08%、112.09%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125004310a22e76d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125004310a22e76d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MGNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503915418","title":"Macrogenics, Inc.盘中异动 早盘急速下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503915418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503915418?lang=zh_cn&edition=full","pubTime":"2025-01-16 23:05","pubTimestamp":1737039904,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日23时05分，Macrogenics, Inc.股票出现波动，股价快速跳水5.02%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为1.07%。其相关个股中，Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Psyence Biomedical Ltd C/Wts 25/01/2029、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大，Aditxt, Inc.、Palisade Bio, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1657.03%、359.74%、233.05%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Aditxt, Inc.、Channel Therapeutics Corporation，振幅分别为131.33%、61.60%、55.47%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116230504abad57d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116230504abad57d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MGNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503426576","title":"Macrogenics, Inc.盘中异动 早盘股价大涨5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503426576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503426576?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951536,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分，Macrogenics, Inc.股票出现异动，股价快速上涨5.92%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Monte Rosa Therapeutics, Inc.、Exicure, Inc.、Generation Bio Co.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.06%、52.88%、35.43%，振幅较大的相关个股有Onconetix, Inc.、Klotho Neurosciences, Inc.、Vincerx Pharma, Inc.，振幅分别为14.29%、12.00%、10.72%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232169604b413&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232169604b413&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503501748","title":"Macrogenics, Inc.盘中异动 快速跳水5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503501748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503501748?lang=zh_cn&edition=full","pubTime":"2025-01-15 01:22","pubTimestamp":1736875369,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日01时22分，Macrogenics, Inc.股票出现异动，股价快速下跌5.05%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Eterna Therapeutics Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Eterna Therapeutics Inc.、Phio Pharmaceuticals Corp.、Soligenix, Inc.较为活跃，换手率分别为967.05%、518.93%、413.76%，振幅较大的相关个股有Eterna Therapeutics Inc.、Matinas Biopharma Holdings, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为170.74%、69.81%、69.33%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115012249a221dd1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115012249a221dd1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502895978","title":"Macrogenics, Inc.盘中异动 早盘股价大跌5.04%报3.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502895978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502895978?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:43","pubTimestamp":1736523835,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时43分，Macrogenics, Inc.股票出现波动，股价大幅下挫5.04%。截至发稿，该股报3.18美元/股，成交量6.6199万股，换手率0.11%，振幅2.90%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为1.42%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110234355aba61497&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110234355aba61497&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500128147","title":"Macrogenics, Inc.盘中异动 股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500128147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500128147?lang=zh_cn&edition=full","pubTime":"2025-01-04 02:32","pubTimestamp":1735929152,"startTime":"0","endTime":"0","summary":"北京时间2025年01月04日02时32分，Macrogenics, Inc.股票出现异动，股价快速拉升5.15%。Macrogenics, Inc.股票所在的生物技术行业中，整体涨幅为0.96%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Scorpius Holdings, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为1786.89%、1680.82%、334.69%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Cyclacel Pharmaceuticals, Inc.、Scorpius Holdings, Inc.，振幅分别为143.91%、123.70%、107.01%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104023232ab9d8c55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104023232ab9d8c55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MGNX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.macrogenics.com","stockEarnings":[{"period":"1week","weight":-0.0786},{"period":"1month","weight":0.3119},{"period":"3month","weight":0.2404},{"period":"6month","weight":1.7643},{"period":"1year","weight":1.1742},{"period":"ytd","weight":1.4037}],"compareEarnings":[{"period":"1week","weight":-0.0382},{"period":"1month","weight":-0.0188},{"period":"3month","weight":0.0891},{"period":"6month","weight":0.0641},{"period":"1year","weight":0.2029},{"period":"ytd","weight":0.0638}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Macrogenics, Inc.于2000年8月14日在美国特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于发现、开发、制造和商业化用于治疗癌症的创新抗体疗法。该公司通过其专有的一套下一代抗体技术平台，开发候选产品，并相信这个平台可以提高单克隆抗体和抗体衍生分子的性能。借助疾病生物学和免疫介导机制的知识，该公司已确定这些候选产品或许能应对现有疗法无法治疗的特定疾病所带来的挑战。公司既开发了针对新癌症靶点的分化分子，又提升了已上市药品的功效。","yearOnYearQuotes":[{"month":1,"riseRate":0.307692,"avgChangeRate":-0.00477},{"month":2,"riseRate":0.615385,"avgChangeRate":0.067213},{"month":3,"riseRate":0.384615,"avgChangeRate":-0.038208},{"month":4,"riseRate":0.538462,"avgChangeRate":0.015209},{"month":5,"riseRate":0.384615,"avgChangeRate":0.025983},{"month":6,"riseRate":0.461538,"avgChangeRate":0.037418},{"month":7,"riseRate":0.25,"avgChangeRate":-0.015431},{"month":8,"riseRate":0.5,"avgChangeRate":0.027209},{"month":9,"riseRate":0.083333,"avgChangeRate":-0.070209},{"month":10,"riseRate":0.5,"avgChangeRate":0.01414},{"month":11,"riseRate":0.615385,"avgChangeRate":0.113412},{"month":12,"riseRate":0.461538,"avgChangeRate":-0.007147}],"exchange":"NASDAQ","name":"MacroGenics Inc.","nameEN":"Macrogenics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MacroGenics Inc.(MGNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供MacroGenics Inc.(MGNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"MacroGenics Inc.,MGNX,MacroGenics Inc.股票,MacroGenics Inc.股票老虎,MacroGenics Inc.股票老虎国际,MacroGenics Inc.行情,MacroGenics Inc.股票行情,MacroGenics Inc.股价,MacroGenics Inc.股市,MacroGenics Inc.股票价格,MacroGenics Inc.股票交易,MacroGenics Inc.股票购买,MacroGenics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MacroGenics Inc.(MGNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供MacroGenics Inc.(MGNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}